Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04886349 · ClinicalTrials.gov registry record
Platelet-rich Plasma for Thumb Carpometacarpal Joint Osteoarthritis
A clinical trial of Thumb Carpometacarpal Joint Osteoarthritis, sponsored by Mayo Clinic.
- Completed
- Registry status
- 170
- Enrollment target
- 1
- Study location
NCT04886349 is a study of Thumb Carpometacarpal Joint Osteoarthritis that has completed, run by Mayo Clinic. The registered enrollment target is 170 participants. The trial reports 1 study location across 1 state.
The verdict
NCT04886349, a study of Thumb Carpometacarpal Joint Osteoarthritis, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 170 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate a case series of patients treated with Platelet-rich plasma for thumb carpometacarpal joint osteoarthritis. Carpometacarpal arthritis is a highly prevalent condition with significant effects on quality of life and function. Meanwhile, platelet-rich plasma has been demonstrated to be an effective treatment for various musculoskeletal conditions.
Conditions Studied
Interventions
- BIOLOGICAL Platelet-rich plasma
Study Locations (1)
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 170 participants |
| Start Date | 2020-10-01 |
| Est. Completion | 2021-04-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04886349
The ClinicalTrials.gov registry entry for NCT04886349 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 170 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Thumb Carpometacarpal Joint Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Platelet-rich plasma is the first listed.
NCT04886349 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT04886349 about?
NCT04886349 is a clinical study titled "Platelet-rich Plasma for Thumb Carpometacarpal Joint Osteoarthritis". The purpose of this study is to investigate a case series of patients treated with Platelet-rich plasma for thumb carpometacarpal joint osteoarthritis. Carpometacarpal arthritis is a highly prevalent condition with significant effects on quality of life and function. Meanwhile, platelet-rich plasma ...
What is the current status of trial NCT04886349?
This trial is currently completed. The enrollment target is 170 participants. The study started on 2020-10-01. Estimated completion is 2021-04-02.
What conditions does trial NCT04886349 study?
This clinical trial studies the following conditions: Thumb Carpometacarpal Joint Osteoarthritis.
What interventions are being tested in trial NCT04886349?
The interventions under investigation include: Platelet-rich plasma (BIOLOGICAL).
Who is sponsoring clinical trial NCT04886349?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04886349 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.